163 related articles for article (PubMed ID: 18368560)
21. Health risk assessment procedures for endocrine disrupting compounds within different regulatory frameworks in the European Union.
Beronius A; Rudén C; Hanberg A; Håkansson H
Regul Toxicol Pharmacol; 2009 Nov; 55(2):111-22. PubMed ID: 19500631
[TBL] [Abstract][Full Text] [Related]
22. Uncertainties for endocrine disrupters: our view on progress.
Daston GP; Cook JC; Kavlock RJ
Toxicol Sci; 2003 Aug; 74(2):245-52. PubMed ID: 12730617
[TBL] [Abstract][Full Text] [Related]
23. The endocrine effects of mercury in humans and wildlife.
Tan SW; Meiller JC; Mahaffey KR
Crit Rev Toxicol; 2009; 39(3):228-69. PubMed ID: 19280433
[TBL] [Abstract][Full Text] [Related]
24. [UV risk perception by the general public: results of a representative questionnaire in Germany].
Börner F; Greinert R; Schütz H; Wiedemann P
Gesundheitswesen; 2010 Dec; 72(12):e89-97. PubMed ID: 20049688
[TBL] [Abstract][Full Text] [Related]
25. Occupational exposure to potential endocrine disruptors: further development of a job exposure matrix.
Brouwers MM; van Tongeren M; Hirst AA; Bretveld RW; Roeleveld N
Occup Environ Med; 2009 Sep; 66(9):607-14. PubMed ID: 19286684
[TBL] [Abstract][Full Text] [Related]
26. Structure and content of chronic kidney disease information on the World Wide Web: barriers to public understanding of a pandemic.
Calderón JL; Zadshir A; Norris K
Nephrol News Issues; 2004 Oct; 18(11):76, 78-9, 81-4. PubMed ID: 15551616
[TBL] [Abstract][Full Text] [Related]
27. The potential for use of gastropod molluscs as bioindicators of endocrine disrupting compounds in the terrestrial environment.
Hall CM; Rhind SM; Wilson MJ
J Environ Monit; 2009 Mar; 11(3):491-7. PubMed ID: 19280027
[TBL] [Abstract][Full Text] [Related]
28. Low dose mixture effects of endocrine disrupters: implications for risk assessment and epidemiology.
Kortenkamp A
Int J Androl; 2008 Apr; 31(2):233-40. PubMed ID: 18248400
[TBL] [Abstract][Full Text] [Related]
29. Patients' reasons for refraining from discussing internet health information with their healthcare providers.
Imes RS; Bylund CL; Sabee CM; Routsong TR; Sanford AA
Health Commun; 2008 Nov; 23(6):538-47. PubMed ID: 19089701
[TBL] [Abstract][Full Text] [Related]
30. Endocrine disrupting pesticides: implications for risk assessment.
McKinlay R; Plant JA; Bell JN; Voulvoulis N
Environ Int; 2008 Feb; 34(2):168-83. PubMed ID: 17881056
[TBL] [Abstract][Full Text] [Related]
31. Endocrine disrupting pesticides: a leading cause of cancer among rural people in Pakistan.
Ejaz S; Akram W; Lim CW; Lee JJ; Hussain I
Exp Oncol; 2004 Jun; 26(2):98-105. PubMed ID: 15273660
[TBL] [Abstract][Full Text] [Related]
32. [Access to own health information and services on the Internet by disability pensioners and other citizens].
Halldórsdóttir G; Thoroddsen AS
Laeknabladid; 2008 Nov; 94(11):729-35. PubMed ID: 18974434
[TBL] [Abstract][Full Text] [Related]
33. Pharmaceuticals, personal care products and endocrine-disrupting chemicals in U.S. surface and finished drinking waters: a proposed ranking system.
Kumar A; Xagoraraki I
Sci Total Environ; 2010 Nov; 408(23):5972-89. PubMed ID: 20869754
[TBL] [Abstract][Full Text] [Related]
34. Patient use of the Internet to obtain health information.
Kershaw A
Nurs Times; 2003 Sep 9-15; 99(36):30-2. PubMed ID: 14533432
[TBL] [Abstract][Full Text] [Related]
35. [Human ecology and interdisciplinary cooperation for primary prevention of environmental risk factors for public health].
Dobrowolski JW
Przegl Lek; 2007; 64 Suppl 4():35-41. PubMed ID: 18540323
[TBL] [Abstract][Full Text] [Related]
36. Informed decisions about protecting and promoting public health: rationale for a National Human Exposure Assessment Survey.
Sexton K; Callahan MA; Bryan EF; Saint CG; Wood WP
J Expo Anal Environ Epidemiol; 1995; 5(3):233-56. PubMed ID: 8814771
[TBL] [Abstract][Full Text] [Related]
37. The possible role of endocrine disrupting chemicals in the aetiology of cryptorchidism and hypospadias: a population-based case-control study in rural Sicily.
Carbone P; Giordano F; Nori F; Mantovani A; Taruscio D; Lauria L; Figà-Talamanca I
Int J Androl; 2007 Feb; 30(1):3-13. PubMed ID: 16824044
[TBL] [Abstract][Full Text] [Related]
38. An evaluation of endocrine modulators: implications for human health.
Juberg DR
Ecotoxicol Environ Saf; 2000 Feb; 45(2):93-105. PubMed ID: 10648129
[TBL] [Abstract][Full Text] [Related]
39. Human health and endocrine disruption: a simple multicriteria framework for the qualitative assessment of end point specific risks in a context of scientific uncertainty.
Martin OV; Lester JN; Voulvoulis N; Boobis AR
Toxicol Sci; 2007 Aug; 98(2):332-47. PubMed ID: 17255114
[TBL] [Abstract][Full Text] [Related]
40. Australian study on public knowledge of human genetics and health.
Molster C; Charles T; Samanek A; O'Leary P
Public Health Genomics; 2009; 12(2):84-91. PubMed ID: 19039252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
